Zobrazeno 1 - 10
of 4 632
pro vyhledávání: '"HER-2/Neu"'
Autor:
Juan Alors-Ruiz, Salomé Sanz-Viedma, Francisco Javier Fernández-Garcia, Francisco Sendra-Portero
Publikováno v:
European Journal of Breast Health, Vol 20, Iss 2, Pp 94-101 (2024)
Objective: High rates of negative sentinel lymph node biopsy (SLNB) in clinically node-negative (cN0) breast cancer (BC) after neoadjuvant chemotherapy (NAC) have been described. These results are associated with triple-negative (TNBC) and human epid
Externí odkaz:
https://doaj.org/article/4c001e607be04e0e95137bc01358fec1
Publikováno v:
Cancer Treatment and Research Communications, Vol 41, Iss , Pp 100840- (2024)
Introduction: Thyroid cancer is an important endocrine malignancy worldwide, including papillary carcinoma, which is responsible for more than 90 % of thyroid malignancies. Human epidermal growth factor receptor 2 (Her-2/neu) overexpression plays a s
Externí odkaz:
https://doaj.org/article/155921e696f746758e0b29cead1abbfa
Publikováno v:
Türk Patoloji Dergisi, Vol 39, Iss 1, Pp 55-63 (2023)
Objective: There is not enough data in the literature regarding Her-2 overexpression in uterine carcinosarcomas or its association with the prognosis. The aim of this study was to determine the Her-2 overexpression rate in uterine carcinosarcoma and
Externí odkaz:
https://doaj.org/article/eb39aef5f66d4b329f2526efa1ca4fa2
Autor:
Emile Gogineni, Blake E. Sells, Khaled Dibs, Sachin R. Jhawar, Catherine T. Haring, Abberly L. Limbach, David J. Konieczkowski, Sung J. Ma, Simeng Zhu, Sujith Baliga, Darrion L. Mitchell, John C. Grecula, Marcelo Bonomi, Priyanka Bhateja, Matthew O. Old, Nolan B. Seim, Stephen Y. Kang, James W. Rocco, Arnab Chakravarti, Dukagjin M. Blakaj, Mauricio E. Gamez
Publikováno v:
Cancers, Vol 16, Iss 6, p 1204 (2024)
Background: Salivary duct carcinomas (SDC) are a rare and aggressive subtype of salivary gland neoplasm. They can present with distinct immunoprofiles, such as androgen receptor (AR) and HER-2/Neu-positivity. To date, no consensus exists on how to be
Externí odkaz:
https://doaj.org/article/08edb3f9b9e440929ab7c0e1557b4c73
Autor:
Joshua Tobias, Sandra Högler, Martin Raigel, Diego Shih-Chieh Lin, Yee Chao, Lukas Kenner, Erika Garner-Spitzer, Sharon Yavrom, Nicholas J. Ede, Christoph C. Zielinski, Michael Kundi, Ursula Wiedermann
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 287 (2023)
Her-2/neu-targeting therapy by passive application with trastuzumab is associated with acquired resistance and subsequent metastasis development, which is attributed to the upregulation of tumoral PD-L1 expression and the downregulation of Her-2/neu.
Externí odkaz:
https://doaj.org/article/bec8d8a4bc6f4924bd71e225660cc70c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joshua Tobias, Mirjana Drinić, Sandra Högler, Katharina Ambroz, Karin Baier, Petra Kodajova, Erwin Tomasich, Anna S. Berghoff, Anna Schmid, Erika Garner-Spitzer, Lukas Kenner, Michael Kundi, Christoph C. Zielinski, Ursula Wiedermann
Publikováno v:
Translational Oncology, Vol 19, Iss , Pp 101378- (2022)
In pre-clinical and clinical settings, active immunization with a Her-2/neu vaccine (HerVaxx), comprising B-cell peptide from Trastuzumab binding site, has been shown to reduce primary tumor growth via induction of polyclonal anti-tumor immune respon
Externí odkaz:
https://doaj.org/article/7d599b48fb6542b08b70ca40b801fdb5
Autor:
Maria Goulielmaki, Savvas Stokidis, Theodoros Anagnostou, Ioannis F. Voutsas, Angelos D. Gritzapis, Constantin N. Baxevanis, Sotirios P. Fortis
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 6, p 5954 (2023)
HER-2/neu is the human epidermal growth factor receptor 2, which is associated with the progression of prostate cancer (PCa). HER-2/neu-specific T cell immunity has been shown to predict immunologic and clinical responses in PCa patients treated with
Externí odkaz:
https://doaj.org/article/ced3b65d8c7e4e86892919b74ca891e8
Autor:
Asma Rasheed, Muhammad Afaaq Agha, Lubna Humayun, Sana Tariq, Nasir Mehmood Chughtai, Farah Bano Niazi
Publikováno v:
Proceedings, Vol 34, Iss 1, Pp 30-38 (2020)
Introduction: Prognosis and management of breast cancer are influenced by the classic variables such as histologic type and grade, tumor size, lymph node status, status of hormonal receptors- i.e. estrogen receptor (ER) and progesterone receptor (PR)
Externí odkaz:
https://doaj.org/article/62a29006c8c140018c734816121d44bd
Autor:
Pragya Jain, Surbhi Goyal, Geeta Chauhan, Kaushik Majumdar, Shahajad Ali, Puja Sakhuja, Anil K Agarwal
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 63, Iss 2, Pp 214-220 (2020)
Background: Gall bladder carcinoma (GBC) is an aggressive malignancy with high mortality and aggressive course, with palliation as the only available option. Objectives: To evaluate frequency of HER-2/neu overexpression in GBC and to seek its correla
Externí odkaz:
https://doaj.org/article/4d2324b65ff24f45883ece18b5e8d79e